Metropolis Healthcare Limited

NSEI:METROPOLIS Stock Report

Market Cap: ₹103.6b

Metropolis Healthcare Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Surendran Chemmenkotil

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.8yrs
CEO ownershipn/a
Management average tenureless than a year
Board average tenure5.3yrs

Recent management updates

Recent updates

Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 13
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Aug 14
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

May 24
Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Mar 28
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Jan 13
Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Dec 23
Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Sep 08
Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Jun 20
Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Mar 14
Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Feb 13
Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Sep 25
Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Sep 10
Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Jun 07
Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

May 16
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Mar 17
Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Jan 29
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Dec 14
Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Oct 12
Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Aug 27
Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

Jul 06
Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

CEO Compensation Analysis

How has Surendran Chemmenkotil's remuneration changed compared to Metropolis Healthcare's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹1b

Jun 30 2024n/an/a

₹1b

Mar 31 2024n/an/a

₹1b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹52m₹13m

₹1b

Compensation vs Market: Insufficient data to establish whether Surendran's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Insufficient data to compare Surendran's compensation with company performance.


CEO

Surendran Chemmenkotil

1.8yrs

Tenure

₹52,318,552

Compensation

Mr. Surendran Chemmenkotil is Chief Executive Officer of Metropolis Healthcare Limited from January 2, 2023. He is a seasoned leader with rich and diverse experience across consumer facing companies such a...


Leadership Team

NamePositionTenureCompensationOwnership
Ameera Shah
Executive Chairperson16.5yrs₹47.88m0.35%
₹ 367.5m
Sushil Shah
Founder & Chairman Emeritusno data₹18.00m18.44%
₹ 19.1b
Surendran Chemmenkotil
Chief Executive Officer1.8yrs₹52.32mno data
Aditya Shinde
Interim Chief Financial Officerno datano datano data
Kannan Alangadan
Chief Operating Officerno datano datano data
Kirti Chadha
Chief Scientific & Innovation Officerno datano datano data
Pinakin Shah
Chief Information Officerless than a yearno datano data
Kamlesh Kulkarni
Head of Legal & Secretarial and Compliance Officerless than a yearno datano data
Jeyasingh Balakrishnan
Head of Public Relations & Corporate Communications3.2yrsno datano data
Mohan Menon
Chief Marketing Officer1.3yrsno datano data
Ishita Medhekar
Chief People Officer4.8yrsno datano data
Nilesh Shah
President of Internal Assurance & Advisor to CEOno datano datano data

1.0yrs

Average Tenure

45yo

Average Age

Experienced Management: METROPOLIS's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Ameera Shah
Executive Chairperson16.5yrs₹47.88m0.35%
₹ 367.5m
Sushil Shah
Founder & Chairman Emeritus19.3yrs₹18.00m18.44%
₹ 19.1b
Anita Ramachandran
Non-Executive Independent Director4.5yrs₹2.18mno data
Sanjay Bhatnagar
Non-Executive Independent Director6.2yrs₹1.73mno data
Vivek Gambhir
Non-Executive Independent Director6.2yrs₹1.85m0.00028%
₹ 290.1k
Ranganathan Subramanian
Independent Directorless than a year₹500.00kno data
Hemant Sachdev
Non-Executive Independent Director3.5yrsno datano data
Aparna Rajadhyaksha
Non-Executive Directorless than a yearno datano data

5.3yrs

Average Tenure

58.5yo

Average Age

Experienced Board: METROPOLIS's board of directors are considered experienced (5.3 years average tenure).